Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV

Anti-glaucoma latanoprost-loaded ocular implants provide prolonged delivery and enhanced bioavailability relative to the conventional eye drops. This study aims at the development and validation of a reversed-phase high-performance liquid chromatography method for quantitative analysis of nanogram l...

Full description

Bibliographic Details
Published in:Journal of Chromatographic Science
Main Author: Soliman K.; Jirjees F.; Sonawane R.; Sheshala R.; Wang Y.; Jones D.; Singh T.R.R.
Format: Article
Language:English
Published: Oxford University Press 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099321329&doi=10.1093%2fchromsci%2fbmaa078&partnerID=40&md5=5907a9c4ff55256dc76c97bc49986351
id 2-s2.0-85099321329
spelling 2-s2.0-85099321329
Soliman K.; Jirjees F.; Sonawane R.; Sheshala R.; Wang Y.; Jones D.; Singh T.R.R.
Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
2021
Journal of Chromatographic Science
59
1
10.1093/chromsci/bmaa078
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099321329&doi=10.1093%2fchromsci%2fbmaa078&partnerID=40&md5=5907a9c4ff55256dc76c97bc49986351
Anti-glaucoma latanoprost-loaded ocular implants provide prolonged delivery and enhanced bioavailability relative to the conventional eye drops. This study aims at the development and validation of a reversed-phase high-performance liquid chromatography method for quantitative analysis of nanogram levels of latanoprost in the eye, and for the first time, compares the use of fluorescence vs ultraviolet (UV) detectors in latanoprost quantification. The mobile phase was composed of acetonitrile:0.1% v/v formic acid (60:40, v/v) with a flow rate of 1 mL/min and separation was done using a C18 column at temperature 40◦C. The fluorescence excitation and emission wavelengths were set at 265 and 285 nm, respectively, while the UV absorption was measured at 200 nm. The latanoprost concentration-peak area relationship maintained its linearity (R2 = 0.9999) over concentration ranges of 0.063-10 μg/mL and 0.212-10 μg/mL for the fluorescence and UV detectors, respectively. The UV detector showed better precision, while the fluorescence detector exhibited higher robustness and greater sensitivity, with a detection limit of 0.021 μg/mL. The fluorescence detector was selected for quantification of latanoprost released from ocular implants in vitro and in porcine ocular tissues. The developed method is a robust, rapid and cost-effective alternative to liquid chromatography-mass spectrometry for routine analysis of latanoprost released from ocular implants. © The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com
Oxford University Press
219665
English
Article

author Soliman K.; Jirjees F.; Sonawane R.; Sheshala R.; Wang Y.; Jones D.; Singh T.R.R.
spellingShingle Soliman K.; Jirjees F.; Sonawane R.; Sheshala R.; Wang Y.; Jones D.; Singh T.R.R.
Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
author_facet Soliman K.; Jirjees F.; Sonawane R.; Sheshala R.; Wang Y.; Jones D.; Singh T.R.R.
author_sort Soliman K.; Jirjees F.; Sonawane R.; Sheshala R.; Wang Y.; Jones D.; Singh T.R.R.
title Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
title_short Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
title_full Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
title_fullStr Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
title_full_unstemmed Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
title_sort Latanoprost quantification in ocular implants and tissues: HPLC-fluorescence vs HPLC-UV
publishDate 2021
container_title Journal of Chromatographic Science
container_volume 59
container_issue 1
doi_str_mv 10.1093/chromsci/bmaa078
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099321329&doi=10.1093%2fchromsci%2fbmaa078&partnerID=40&md5=5907a9c4ff55256dc76c97bc49986351
description Anti-glaucoma latanoprost-loaded ocular implants provide prolonged delivery and enhanced bioavailability relative to the conventional eye drops. This study aims at the development and validation of a reversed-phase high-performance liquid chromatography method for quantitative analysis of nanogram levels of latanoprost in the eye, and for the first time, compares the use of fluorescence vs ultraviolet (UV) detectors in latanoprost quantification. The mobile phase was composed of acetonitrile:0.1% v/v formic acid (60:40, v/v) with a flow rate of 1 mL/min and separation was done using a C18 column at temperature 40◦C. The fluorescence excitation and emission wavelengths were set at 265 and 285 nm, respectively, while the UV absorption was measured at 200 nm. The latanoprost concentration-peak area relationship maintained its linearity (R2 = 0.9999) over concentration ranges of 0.063-10 μg/mL and 0.212-10 μg/mL for the fluorescence and UV detectors, respectively. The UV detector showed better precision, while the fluorescence detector exhibited higher robustness and greater sensitivity, with a detection limit of 0.021 μg/mL. The fluorescence detector was selected for quantification of latanoprost released from ocular implants in vitro and in porcine ocular tissues. The developed method is a robust, rapid and cost-effective alternative to liquid chromatography-mass spectrometry for routine analysis of latanoprost released from ocular implants. © The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com
publisher Oxford University Press
issn 219665
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1818940561320574976